Nilsine Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.66M | Sell |
8,936
-569
| -6% | -$106K | 0.17% | 133 |
|
|
2025
Q1 | $1.99M | Sell |
9,505
-113
| -1% | -$23.7K | 0.22% | 104 |
|
|
2024
Q4 | $1.71M | Buy |
9,618
+1,983
| +26% | +$352K | 0.18% | 125 |
|
|
2024
Q3 | $1.51M | Sell |
7,635
-558
| -7% | -$110K | 0.2% | 128 |
|
|
2024
Q2 | $1.41M | Buy |
8,193
+42
| +0.5% | +$7.2K | 0.19% | 130 |
|
|
2024
Q1 | $1.48M | Buy |
8,151
+498
| +7% | +$90.7K | 0.2% | 126 |
|
|
2023
Q4 | $1.19M | Buy |
7,653
+363
| +5% | +$56.3K | 0.18% | 143 |
|
|
2023
Q3 | $1.09M | Sell |
7,290
-622
| -8% | -$92.7K | 0.16% | 155 |
|
|
2023
Q2 | $1.07M | Sell |
7,912
-95
| -1% | -$12.8K | 0.16% | 161 |
|
|
2023
Q1 | $1.28M | Buy |
+8,007
| New | +$1.28M | 0.2% | 133 |
|